30 Rockefeller Plaza
New York, NY 10112
United States of America
+1 (212) 408-5507
ssedor@chadbourne.com
Download a V-Card
|
Sumantha
R.
Sedor
Associate
Practice Description
Sumantha Sedor has experience in a broad range of matters, including assisting life sciences companies with licensing transactions, distribution and supply arrangements, product acquisitions, joint ventures, strategic alliances and corporate partnering, along with experience in securitization arrangements, corporate restructuring, private investments in public companies (PIPE) transactions, corporate compliance and disclosure, corporate governance and other general corporate matters. Ms. Sedor also assists high net worth individuals in connection with their closely held domestic and international corporations in similar corporate undertakings.
Representative Matters
- Advising and representing both domestic and international pharmaceutical companies in connection with various licensing agreements, distribution and supply arrangements, joint ventures, product acquisitions, authorized generic agreements, corporate restructuring, corporate governance and other various corporate matters.
- Representing the Spiegel Creditor Trust on securitization arrangements, corporate governance and general corporate matters.
- Assisted in the representation of the largest shareholder of a publicly owned technology company in a PIPE financing.
- Involved in the representation of Citigroup in connection with the restructuring of aircraft leases.
Activities and Affiliations
Ms. Sedor is a member of the Association of the Bar of the City of New York.
Publications
-
"Antidotes for an Ailing Biotechnology Sector," Genetic Engineering & Biotechnology News, September 1, 2009
-
"SEC Adopts Long-Awaited Final Rules to Ease the Deregistration Process for Foreign Private Issuers," Client Alert, April 10, 2007
-
"SEC Reproposes Rules to Ease the Deregistration Process for Foreign Private Issuers," Client Alert, January 9, 2007
-
"SEC's Proposed Rules to Ease Deregistration Process for Foreign Private Issuers," Client Alert, January 31, 2006
-
"Treasury and IRS Issue 'Second Round' of 409A Guidance: What You Need to Know and Do Before Year End," Client Alert, October 27, 2005
-
"Antidotes for an Ailing Biotechnology Sector," Genetic Engineering & Biotechnology News, September 1, 2009
-
"SEC Adopts Long-Awaited Final Rules to Ease the Deregistration Process for Foreign Private Issuers," Client Alert, April 10, 2007
-
"SEC Reproposes Rules to Ease the Deregistration Process for Foreign Private Issuers," Client Alert, January 9, 2007
-
"SEC's Proposed Rules to Ease Deregistration Process for Foreign Private Issuers," Client Alert, January 31, 2006
-
"Treasury and IRS Issue 'Second Round' of 409A Guidance: What You Need to Know and Do Before Year End," Client Alert, October 27, 2005
-
"New Guidance Clarifies 409A’s Application to Separation Pay Arrangements," Client Alert, October 27, 2005
-
"Treasury and IRS Issue Long-Awaited 'Second Round' of 409A Guidance," Client Alert, September 29, 2005
[ more publications ]
|
|
|